Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-16

Clinical Trial Update: Naloxone, Hypoglycemia and Exercise [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating Naloxone effects on hypoglycemia during exercise in individuals with Type 1 diabetes; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone (Naloxone)

Snippet

Sponsor: University of Minnesota | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2024-04-16